###begin article-title 0
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits
###end article-title 0
###begin p 1
###xml 159 166 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 1037 1041 <span type="species:ncbi:10090">mice</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
###xml 1378 1382 <span type="species:ncbi:10090">mice</span>
###xml 1496 1501 <span type="species:ncbi:10090">mouse</span>
Gaucher disease is caused by defective acid beta-glucosidase (GCase) function. Saposin C is a lysosomal protein needed for optimal GCase activity. To test the in vivo effects of saposin C on GCase, saposin C deficient mice (C-/-) were backcrossed to point mutated GCase (V394L/V394L) mice. The resultant mice (4L;C*) began to exhibit CNS abnormalities approximately30 days: first as hindlimb paresis, then progressive tremor and ataxia. Death occurred approximately48 days due to neurological deficits. Axonal degeneration was evident in brain stem, spinal cord and white matter of cerebellum accompanied by increasing infiltration of the brain stem, cortex and thalamus by CD68 positive microglial cells and activation of astrocytes. Electron microscopy showed inclusion bodies in neuronal processes and degenerating cells. Accumulation of p62 and Lamp2 were prominent in the brain suggesting the impairment of autophagosome/lysosome function. This phenotype was different from either V394L/V394L or C-/- alone. Relative to V394L/V394L mice, 4L;C* mice had diminished GCase protein and activity. Marked increases (20- to 30-fold) of glucosylsphingosine (GS) and moderate elevation (1.5- to 3-fold) of glucosylceramide (GC) were in 4L;C* brains. Visceral tissues had increases of GS and GC, but no storage cells were found. Neuronal cells in thick hippocampal slices from 4L;C* mice had significantly attenuated long-term potentiation, presumably resulting from substrate accumulation. The 4L;C* mouse mimics the CNS phenotype and biochemistry of some type 3 (neuronopathic) variants of Gaucher disease and is a unique model suitable for testing pharmacological chaperone and substrate reduction therapies, and investigating the mechanisms of neuronopathic Gaucher disease.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 137 140 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gba</italic>
###xml 293 294 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C1">1</xref>
###xml 295 296 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C2">2</xref>
###xml 535 536 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C2">2</xref>
###xml 688 689 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C3">3</xref>
###xml 690 691 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C5">5</xref>
###xml 1003 1004 1000 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C2">2</xref>
###xml 1119 1120 1116 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C6">6</xref>
###xml 1121 1122 1118 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C8">8</xref>
###xml 1336 1337 1333 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C3">3</xref>
###xml 1338 1339 1335 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C9">9</xref>
###xml 1340 1342 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C10">10</xref>
###xml 117 122 <span type="species:ncbi:9606">human</span>
###xml 124 127 <span type="species:ncbi:9606">GBA</span>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
Gaucher disease is caused by inherited deficiency of acid beta-glucosidase (GCase). The mutations in the GCase gene [human (GBA), mouse (gba)] lead to defective hydrolysis of glucosylceramide (GC) that results in the storage of GC in the liver, spleen, bone marrow and central nervous system (1,2). Clinically, two major categories of Gaucher disease have been delineated, non-neuronopathic and neuronopathic. Type 1 includes the non-neuropathic variants, whereas types 2 and 3 encompass the acute and subacute neuronopathic variants (2). Type 2 is rare (<1/500 000 live births) and manifests progressive neuronopathic disease within the first 2-3 months with median survival of <1 year (3-5). Death results from severe progressive CNS and lung involvement. Type 3 is more slowly progressive, rare (1/100 000 live births) and has a wide spectrum of phenotypes extending from early severe visceral and mild neuropathic variants to mild visceral disease with uncontrollable seizures later in adolescence (2). In the neuronopathic variants, GC and glucosylsphingosine (GS) accumulations have been documented in the brain (6-8). Unlike the visceral disease, pathogenesis in the CNS is not related to large storage cell (macrophages) accumulations but, rather, to neuronal death/drop-out that is propagated by toxic effects of GS and/or GC (3,9,10).
###end p 3
###begin p 4
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C11">11</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C12">12</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C13">13</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C14">14</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C15">15</xref>
###xml 716 724 716 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C11">11</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C16">16</xref>
###xml 738 745 738 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Saposins (A, B, C and D) are small (80 amino acids) protein enhancers of specific glycosphingolipid (GSL) hydrolase activities (11). They derive from a single precursor protein, prosaposin, by proteolysis in the late endosome and lysosome (12). Among the four saposins, only saposin C has activation and anti-proteolytic protective effects toward GCase (13). Deficiency of saposin C leads to a variant form of Gaucher disease with GC accumulation in macrophages and in the CNS (14). Saposin C's mode of GCase activation is related to induced alterations of the membrane bilayer that facilitate enzyme and substrate interaction (15). Although the involvement of saposin C in the degradation of GC is well-established in vitro (11,16), the in vivo mechanisms of its action are not fully understood.
###end p 4
###begin p 5
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gba</italic>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C17">17</xref>
###xml 183 184 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C8">8</xref>
###xml 218 220 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C18">18</xref>
###xml 333 335 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C18">18</xref>
###xml 441 443 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C19">19</xref>
###xml 444 446 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C20">20</xref>
###xml 548 551 536 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gba</italic>
###xml 679 681 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C19">19</xref>
###xml 682 684 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C20">20</xref>
###xml 990 992 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C14">14</xref>
###xml 1156 1158 1144 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C21">21</xref>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 366 371 <span type="species:ncbi:10090">mouse</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 649 654 <span type="species:ncbi:9606">human</span>
###xml 1313 1318 <span type="species:ncbi:10090">mouse</span>
Knockout of the gba locus in mice abolishes GCase activity and leads to neonatal death (17). In brains of these GCase knockout mice, GS levels are increased by approximately100-fold (8) along with the increases of GC (18). Although neuronal loss is not observed, some GC storage in neurons is observed in spinal cord and brain stem (18). Recently, more viable GCase mouse models with acute neuronopathic Gaucher disease have been generated (19,20). By either rescue of the skin of mice that are null in all other cells or specifically knocking out gba only in neurons, longer lived (2-3 weeks) acute neuronopathic variants were created as mimics of human type 2 Gaucher disease (19,20). However, the foreshortened lifespan limits biochemical and neuronopathological studies of the disease progression. Additional efforts were taken to create Gaucher disease models include knock-ins of point mutations (e.g. V394L, D409H or D409V) with or without combinations with hypomorphic prosaposins (14). The latter models develop storage cells in visceral and GC accumulation in visceral, but have complex GSL accumulations in the CNS due to prosaposin deficiency (21). A principle impediment to understanding the pathophysiology and therapeutic developments for the CNS variants has been the lack of viable neuronopathic mouse models with sufficient lifespans.
###end p 5
###begin p 6
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 126 131 <span type="species:ncbi:10090">mouse</span>
In this study, a new mouse model was generated by cross-breeding of the V394L GCase homozygote into the saposin C null (C-/-) mouse. Deficiency of saposin C led to additional reductions of the V394L GCase and increases of GC and GS levels. This viable model developed neurological deficits analogous to subacute neuronopathic Gaucher disease.
###end p 6
###begin title 7
RESULTS
###end title 7
###begin title 8
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Generation of 4L;C* mice
###end title 8
###begin p 9
###xml 90 92 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C22">22</xref>
###xml 241 243 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C23">23</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
The 4L/4L mice have approximately10% WT GCase activity and no apparent CNS abnormalities (22). Saposin C-/- mice showed approximately60% of WT GCase activity and protein in several tissues and developed a CNS phenotype around 1 year of age (23).
###end p 9
###begin p 10
###xml 229 230 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F1">1</xref>
###xml 612 613 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F1">1</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:8839">duck</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
The 4L;C* mice were born in normal sized litters with expected Mendelian ratios for the offspring. They began showing phenotypic abnormalities and neurological deficits approximately30 days and died by approximately48 days (Fig. 1) due to inability to eat and drink. At approximately35 days, the 4L;C* mice had outwardly splayed hind limbs and their stomachs dragged when walking. The gait of 4L;C* mice was a duck-like waddling due to the splaying of their hindlimbs and apparent stiffness and progressive bradykinesia, relative to WT, that progressed until death when the 4L;C* mice were nearly immobile (Fig. 1). Also, grip weakness of the 4L;C* mice was progressive. By age 43-48 days, they weighed 25% less than the control groups (C+/-, 4L/4L, 4L/4L;C+/- and wt/wt; wt/wt) with an average of 17.2 g compared with 23.0 g in controls. All control mice had weights and lifespans similar to WT.
###end p 10
###begin p 11
###xml 40 41 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 151 152 151 152 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 83 87 <span type="species:ncbi:8839">duck</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
Phenotypes and lifespan of 4L;C* mice. (A) 4L;C* mouse showed hindlimb paresis and duck waddling by 47 days. They weighed 25% less than control mice. (B) Kaplan-Meier survival curves for 4L;C* and control (WT and C+/-) mice. Average lifespan of 4L;C* mice was 48 days.
###end p 11
###begin title 12
Electrophysiology analyses
###end title 12
###begin p 13
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F2">2</xref>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
The neuronal cells of hippocampal sections in the brain were recorded as excitatory postsynaptic potential (EPSP) slope potentiation (LTP, long-term potentiations) on a MED64 array chamber in the warm artificial cerebral spinal fluid. After accounting for a baseline of activity, the hippocampi from 4L;C* mice at 35 days showed significant (P < 0.05) decreases of LTP, compared with the WT mice (Fig. 2), suggesting an overall reduction of hippocampal plasticity in 4L;C* mice.
###end p 13
###begin p 14
###xml 253 254 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 363 364 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 382 383 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
Electrophysiology analyses of long-term potentiation (LTP). The slope of resulting EPSPs from the parasagittal sections (350 microm) of hippocampal CA1 region was recorded. The slopes of the EPSP (LTP) in 35 days 4L;C* (black circle) was significantly (P < 0.05) decreased compared with WT (open circle) mice after recording for 90 min following stimulation. WT, n = 6 mice; 4L;C*, n = 8 mice.
###end p 14
###begin title 15
Histological analyses
###end title 15
###begin p 16
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F3">3</xref>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F4">4</xref>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F4">4</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C24">24</xref>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F5">5</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C25">25</xref>
###xml 978 979 978 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F5">5</xref>
###xml 1160 1161 1160 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F5">5</xref>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 1378 1382 <span type="species:ncbi:10090">mice</span>
###xml 1447 1451 <span type="species:ncbi:10090">mice</span>
In the hematoxylin and eosin (H&E) stained sections, axonal degeneration (Fig. 3 arrow) was evident in the brain stem, spinal cord and white matter of cerebellum of 4L;C* mice at 46 days. The anti-CD68 positive microglial cells were numerous in the brainstem, basal ganglion, thalamus, hypothalamus, cerebral cortex and spinal cord (Fig. 4A). Moderate astrogliosis as evidenced by anti-GFAP positivity was observed in the midbrain, brainstem, multiform layer of cerebral cortex, thalamus, corpus collosum, cerebellum and spinal cord (Fig. 4B). The enhanced microglial cell activation and astrogliosis indicates proinflammation in 4L;C* CNS. Lamp2 is a membrane protein located in the late endosome and lysosome (24). Lamp2 immunoreactivity was increased in thalamus (Fig. 5), brain stem, basal ganglion and white matter of cerebellum. P62/sequestosome 1 is involved in autophagic clearance of ubiquitinated proteins (25). Enhanced p62 signals were intense in the thalamus (Fig. 5) and scattered p62 positive cells were in brain stem, basal ganglion and cortex. Accumulation of p62 was found in the neurons and astrocytes, but not in the microglial cells (Fig. 5B). These results suggest impairment of autophagosome and lysosome apparatus in 4L;C* brain. Tunnel assays in 4L;C* CNS tissues were negative. No histological abnormalities were found in the visceral tissues of 4L;C* mice. The brain and spinal cord morphology in saposin C-/- and 4L/4L mice were normal at 46 days.
###end p 16
###begin p 17
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
Neuropathology in 4L;C* mice. The sections from 46-day 4L;C* mice were stained with H&E. Axonal degeneration (arrows) was present in brain stem, spinal cord and white matter of cerebellum in 4L;C* mice. WT brain stem, spinal cord and cerebellum had normal morphology.
###end p 17
###begin p 18
###xml 34 35 34 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 340 341 340 341 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
Neuroinflammation in 4L;C* mice. (A) CD 68 staining (brown) in 46-day 4L;C* and WT mice. [A1]WT brain stem had background levels of CD68 staining. CD68 positive staining demonstrated activation of macrophage/microglial cells in 4L;C* brain stem [A2], spinal cord [A3] and thalamus [A4]. Methyl green (green) was used to stain cell nuclei. (B) GFAP staining (green) in 46 days 4L;C* and WT mice. [B1] WT brain stem had background level GFAP staining. Enhanced GFAP staining presented in 4L;C* brain stem [B2], thalamus [B3] and cerebellum [B4]. Cell nuclei were stained with DAPI (blue).
###end p 18
###begin p 19
###xml 50 51 50 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 281 282 281 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Accumulation of p62 and Lamp2 in 4L;C* thalamus. (A) Frozen sections from 46-day 4L;C* and WT mice were stained with anti-p62 and anti-Lamp2 antibodies, respectively. Both p62 (green) and Lamp2 signals (green) were increased in thalamus of 4L;C* brain relative to the WT control. (B) Colocalization of p62 in neuron, astrocyte or microglial cells in the thalamus of 4L;C* brain. Accumulation of p62 (red) was in neuron (green) stained by anti-NeuN antibody and astrocyte (green) stained with anti-GFAP antibody. Arrows point the p62 containing cells. Yellow color cell shows the overlapping of p62 and GFAP or NeuN. p62 (red) was not localized in CD 68 positive microglial cells (green). DAPI (blue) in anti-fade was used for cell nuclei staining.
###end p 19
###begin p 20
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F6">6</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F6">6</xref>
###xml 786 787 786 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F6">6</xref>
###xml 1136 1137 1136 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F6">6</xref>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 838 842 <span type="species:ncbi:10090">mice</span>
###xml 1125 1129 <span type="species:ncbi:10090">mice</span>
Ultrastructural studies of CNS regions revealed the inclusion materials in the neuronal cell processes from brain stem, spinal cord, white matter of cerebellum and midbrain regions of 43-day-old mice (Fig. 6). The inclusions were visualized as electron dense and lucent materials in axonal processes. The storage materials were heterogeneous and coarsely granular. The ultrastructure shows axonal cell processes expanded by numerous tightly packed single-membrane bound bodies consistent with phagolysosomes (Fig. 6C, E and F). The sequestered materials range from dense osmiophilic undigested material to partially digested electron-lucent material. In the hippocampus, dendritic processes contained membrane-like material. Separation of myelin sheath was evident in spinal cord (Fig. 6C), brainstem and midbrain regions of 43-day 4L;C* mice. Degenerating cells and swollen cell processes were identified in cortex and hippocampal regions. In many processes, the subcellular organelles were compressed to the periphery by the accumulating storage materials. The general appearance of the soma of neurons was normal in 4L;C* mice (Fig. 6D).
###end p 20
###begin p 21
###xml 40 41 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 85 86 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 138 139 138 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 256 257 256 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 299 300 299 300 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 410 411 410 411 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
Ultrastructural features of 4L;C* CNS. (A) Normal midbrain morphology in 43 day WT. (B) Axonal inclusions (arrows) were in 43-day 4L;C*. (C) 4L;C* spinal cord showed storage materials in axonal process (arrow) and separation of myelin layers (arrowhead). (D) Brain stem of 4L;C* had normal neuron. (E) The white matter of cerebellum in 4L;C* mice contained a complex accumulation materials in axonal process. (F) Higher magnification of the complex accumulation in cerebellar axons showed amorphous granular inclusions of variable density. The storage materials are heterogeneous and coarsely granular.
###end p 21
###begin title 22
###xml 22 26 <span type="species:ncbi:10090">mice</span>
GCase levels in 4L;C* mice
###end title 22
###begin p 23
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F7">7</xref>
###xml 309 310 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F7">7</xref>
###xml 506 507 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F7">7</xref>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 374 379 <span type="species:ncbi:10090">mouse</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
The GCase activity in 4L;C* was reduced to <10% of WT in liver, lung, spleen, brain and cultured skin fibroblasts. These levels were 40-60% of those in the respective tissues of 4L/4L mice (Fig. 7A). The GCase activity (WT enzyme) in saposin C-/- mice was approximately60% of those in saposin C+/+ mice (Fig. 7A). Liver GCase protein was determined by immunoblot using anti-mouse GCase antibody. Consistent with the activity data, 4L;C* mice had approximately40% of 4L/4L levels GCase protein levels (Fig. 7B). These results indicate that the deficiency of saposin C led to a concordant reduction in mutant V394L GCase protein and activity.
###end p 23
###begin p 24
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 197 198 197 198 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 534 535 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 547 548 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
GCase activity and protein in 4L;C* mice. (A) The activities of GCase decreased significantly in 4L;C* liver, brain, lung, spleen and fibroblasts compared with 4L/4L, C-/- and WT tissues (n = 3). (B) GCase protein was decreased in 4L;C* livers by immunoblot analyses using anti-mouse GCase antibody. GCase protein level was normalized to beta-actin signals in the same sample and presented as ratio relative to 4L/4L. A representative immunoblot is shown. The data represented the means +/- SE for three mice assayed in duplicates. **P < 0.01; ***P < 0.001.
###end p 24
###begin title 25
GSL analyses
###end title 25
###begin p 26
###xml 253 254 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F8">8</xref>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 226 231 <span type="species:ncbi:10090">mouse</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 654 659 <span type="species:ncbi:10090">mouse</span>
Relative to WT mice, marked increases of GS were present in cerebral cortex (approximately20-fold) and midbrain (approximately30-fold) from 43-day-old 4L;C* mice. Levels of GS also were massively increased in 43-day-old 4L;C* mouse lung and liver (Fig. 8A). GC levels were increased approximately3-fold in the liver and lung, and by approximately1.5-fold in the cortex and midbrain relative to WT. Increases of ceramide (1.6-fold) and sphingosine (3.4-fold) were found only in the liver of 4L;C*. Lactosylceramide levels was not significantly altered in 4L;C* mice. No excess accumulations of GC and GS were detected in 10 weeks 4L/4L and 13 months C-/- mouse brains (data not shown). Elevated GC (1.3-fold) and GS (6.5-fold) were detected in 4L;C* skin at 14 days.
###end p 26
###begin p 27
###xml 30 31 30 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 140 141 140 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 366 367 366 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 660 661 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 672 673 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 685 686 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 696 697 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
LC/MS analyses of GC and GS. (A) GS levels showed marked increases (20- to 600-fold) by 43 days in 4L;C* cortex, midbrain, liver and lung. (B) Increases of GC (1.5- to 3-fold) were detected in 4L;C cortex, midbrain, liver and lung. These GC and GS levels were normalized to phosphate content in the same sample and presented as fold change relative to WT controls. (C) Both GC (3.4-fold) and GS (132-fold) levels were significantly increased in 4L;C* hippocampus relative to WT. GalCer in 4L;C* hippocampus was at WT level. The hippocampal GC, GS and GalCer levels were normalized to mg protein in the same sample. The data were analyzed by Student's t-test. *P < 0.05; **P < 0.01, ***P < 0.001 (n = 3 mice).
###end p 27
###begin p 28
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP580F8">8</xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
GSL was analyzed in hippocampal tissue from 44-day-old mice. Both GC (3.4-fold) and GS (132-fold) were elevated in 4L;C* mice (Fig. 8C). Galactosylceramide (GalCer) levels in 4L;C* were at WT levels, indicating normal GalCer metabolism in 4L;C* mice. This result suggests a correlation of substrate accumulation with abnormal LTP in 4L;C* mice.
###end p 28
###begin title 29
DISCUSSION
###end title 29
###begin p 30
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C26">26</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C28">28</xref>
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C6">6</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C26">26</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C7">7</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C29">29</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C30">30</xref>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C6">6</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C27">27</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C31">31</xref>
###xml 559 567 559 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 660 662 660 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C32">32</xref>
###xml 774 776 774 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C32">32</xref>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C33">33</xref>
###xml 853 855 853 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C34">34</xref>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C30">30</xref>
###xml 1640 1642 1640 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C25">25</xref>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
###xml 622 630 <span type="species:ncbi:9606">patients</span>
###xml 1165 1169 <span type="species:ncbi:10090">mice</span>
###xml 1306 1310 <span type="species:ncbi:10090">mice</span>
Neuronopathic Gaucher disease variants present with brainstem, cerebellar, thalamic, cerebral cortical and substantia nigra involvement, but the degrees of involvement and affected regions vary among the patients (26-28). The neuropathological involvement has been correlated with the accumulation of GS and GC (6,26) with increased GS mostly associated with the widespread neuron loss in Gaucher disease type 2 (7,29,30). This neuronal loss is also associated with astrogliosis and microglial nodules (6,27). Additionally, GS suppresses neuritogenesis (31). In vitro GC addition to microsomes from type 1, 2 or 3 Gaucher patients stimulated agonist-induced Ca2+ release and this alteration correlated with the level of GC accumulation (32). GS also directly augments the Ca2+ release in an agonist-independent manner in such microsomes (32,33). This Ca2+ release, presumably from endoplasmic reticulum, has been speculated to be responsible for neuron cell death due to GC or GS increases (34). Furthermore, hippocampal CA2-4 regions are significantly involved by neuronal injury in neuronopathic Gaucher disease variants (30). Here, the neuronal deficit in 4L;C* mice was likely caused by excess levels of GS and GC as well as the striking inclusions in axonal and neuronal processes. Furthermore, 4L;C* mice showed impaired hippocampal LTP that correlated with substrate accumulation and abnormal neuronal processes. Negative Tunnel assays in 4L;C* CNS tissues indicate that apoptosis was not the cause of neurodegeneration. The accumulation of p62, an autophagic receptor that mediates autophagic degradation of ubiquitinated proteins (25) and enhanced Lamp2 expression suggest an impairment of protein degradation in the autophagosome and lysosome system that could be the cause of neurodegeneration in this model.
###end p 30
###begin p 31
###xml 388 396 388 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
Comparisons of the saposin C-/- mice and the 4L;C* mice provide insights into the function of saposin C and GCase. Importantly, saposin C provides a proteolytic protective effect for GCase within the lysosome and that its presence is required for the full activity of the enzyme. Here, the singular absence of saposin C led to further decreases in V394L mutant GCase activity as measured in vitro. This GCase protein level was also decreased indicating an increased instability or susceptibility of the mutant protein to proteolysis. Because of this decrease in GCase activity from approximately15 to approximately6% of WT levels, a new phenotype emerged with primarily central nervous system disease and with biochemical evidence of GC and GS storage in the viscera. Furthermore, the reduced V394L GCase activity in the brain was below a threshold to prevent the development of central nervous system disease, since neither the V394L homozygote nor the saposin C-/- mice themselves develop progressive central nervous system disease in the time frame of these studies.
###end p 31
###begin p 32
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C31">31</xref>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
A curious finding was that the level of GC in the brain had only minor changes, unlike the level of GS that showed major increases. GS is known to be highly toxic to cells, particularly neurons (31), and the elevated GS levels led to selective deterioration of the central nervous system in the 4L;C* mice. Although, the levels of GS in visceral tissues, on a fold basis, were similar to or greater than those in the CNS, the visceral organs do not show any major histological abnormalities. The lipid abnormalities were detectable only using MS. Thus, it appears that the visceral tissues are relatively resistant or insensitive to the toxic effects of GS. There is a much greater toxicity to similarly raised levels of GS for CNS cells. This difference in sensitivity may relate to the fact that neurons and glial cells in central nervous system are more vulnerable to GSLs accumulation than the cells in the liver and some other visceral tissues. Within the central nervous system, this disease process is also selective with specific involvement of neurons and some cells within the spinal cord while leaving much of the white matter uninvolved.
###end p 32
###begin p 33
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C23">23</xref>
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 625 630 <span type="species:ncbi:10090">mouse</span>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
###xml 1041 1045 <span type="species:ncbi:10090">mice</span>
It is also clear that saposin C interacts functionally with both WT and mutant GCases. In both the saposin C-/- mouse with WT or with V394L GCases, the amount of enzyme protein present in the central nervous system is diminished compared with saposin C+/+ animals. The amount of WT GCase in saposin C-/- mice appears to be sufficient for the maintenance of central nervous system function in a normal state for periods >12 months and that the eventual phenotype is not clearly related to the accumulation of GC or GS within the CNS. Thus, the axonal degeneration and other histological abnormalities seen in the saposin C-/- mouse must relate to other intrinsic functions of saposin C, unrelated to its activity in promoting optimal GCase function (23). In contrast, the additional decrease in V394L activity caused by the absence of saposin C is below a threshold necessary for the protection of the central nervous system from GS toxicity. The early demise of the 4L;C* mice (48 days) compared with the longer lifespan of the saposin C-/- mice (>20 months), suggests that the toxic effects may be attributed to GS.
###end p 33
###begin p 34
###xml 534 535 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 535 536 535 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 934 939 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 942 944 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C35">35</xref>
###xml 962 963 950 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 963 966 951 954 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
An interesting question is the differential accumulation of GS compared with GC in the brains of 4L;C* mice. Possible explanations include either functions related to saposin C or to the mutant enzyme V394L or both. Saposin C could affect substrate specificity and enhance the activity of GCase to a greater degree toward the deacylated analog, GS, compared with GC. This will be investigated in future studies. An alternative explanation is that the V394L has a preference for GS or GC substrates. GS has an affinity (as measured by Ki) for V394L that is approximately4- to 5-fold decreased compared with WT, and that GC has a normal binding constant for this enzyme (Liou and Grabowski, unpublished data). This suggests a potentially pure kinetic effect of a diminished enzymatic activity in which, once below a threshold, GS, because of its poor binding, cannot engage V394L GCase and cannot be hydrolyzed, whereas GC can. Vaccaro et al. (35) showed that the kcat for GS was approximately100-fold less than that for GC using purified WT GCase. If this also applies to the V394L enzyme and the binding constant is diminished, the accumulation of GS could be explained on the basis of a kinetic phenomenon, based on the decreased ability of V394L to cleave the less preferred substrate.
###end p 34
###begin p 35
###xml 432 440 432 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 615 622 615 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
###xml 570 575 <span type="species:ncbi:10090">mouse</span>
###xml 590 595 <span type="species:ncbi:10090">mouse</span>
Finally, the studies here address the question of whether the toxic agent in neuronopathic Gaucher disease is GC or GS. The 4L;C* mouse accumulates GS to greater relative levels than GC; 4L;C* is nearly a pure GS storage disease that leads to central nervous dysfunction and eventual death. As a pure GC storage disease of CNS is not available, the question of this lipid's toxicity alone cannot be directly addressed. However, the in vitro studies showing toxicity of galactosylsphingosine and GS translate reasonably well to their CNS animal models, i.e. the twitcher mouse and the 4L;C* mouse, respectively. The in vivo toxicity of GS to neurons remains to be clarified. It will be important to address whether a diminution in GS can occur by the use of GC synthase inhibitors, and thereby diminish toxicity of GS. If it is true that GC synthase is responsible for all or most of the synthesis of GC and GS, compounds that inhibit this synthase could be therapeutic to the neuropathic forms of Gaucher disease.
###end p 35
###begin title 36
MATERIALS AND METHODS
###end title 36
###begin title 37
Materials
###end title 37
###begin p 38
###xml 226 227 223 224 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
###xml 334 337 <span type="species:ncbi:10116">Rat</span>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
###xml 793 796 <span type="species:ncbi:9823">pig</span>
###xml 802 807 <span type="species:ncbi:10090">mouse</span>
###xml 884 889 <span type="species:ncbi:10090">mouse</span>
###xml 941 946 <span type="species:ncbi:10090">mouse</span>
###xml 952 957 <span type="species:ncbi:10090">mouse</span>
###xml 1041 1046 <span type="species:ncbi:10090">mouse</span>
###xml 1053 1056 <span type="species:ncbi:10116">rat</span>
The following were from commercial sources: NuPAGE 4-12% Bis-Tris gel, NuPAGE MES SDS running buffer, Anti-GFAP mouse monoclonal antibody conjugated Alexa Fluor 488 (Invitrogen, Carlsband, CA, USA). 4-Methyl-umbelliferyl-beta-d-glucopyranoside (4MU-Glc; Biosynth AG, Switzerland). Sodium taurocholate (Calbiochem, La Jolla, CA, USA). Rat anti-mouse CD68 monoclonal antibodies (Serotec, Oxford, UK). M-PER Mammalian Protein Extraction Reagent, ImmunoPure immobilized Protein G and BCA Protein Assay reagent (Pierce, Rockford, IL, USA). Hybondtrade mark-ECLtrade mark nitrocellulose membrane and ECL detection reagent (Amersham Biosciences, Piscataway, NJ, USA). Anti-fade/DAPI, Methyl green, ABC Vectastain and Alkaline Phosphatase Kit II (Black) (Vector Laboratory, Burlingame, CA, USA). Anti-pig GFAP mouse monoclonal antibody (Sigma, St Louis, MO, USA). Anti-recombinant p62/SQSTM1 mouse monoclonal antibody (Abnova, Taipei, Taiwan). Anti-mouse NeuN mouse monoclonal antibody conjugated Alex Fluor 488 (Millipore, Temecula, CA, USA). Anti-mouse Lamp2 rat monoclonal antibody (Abcam, Cambridge, MA, USA).
###end p 38
###begin title 39
Animal care
###end title 39
###begin p 40
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C23">23</xref>
###xml 377 379 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C36">36</xref>
###xml 380 382 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C37">37</xref>
###xml 466 468 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C22">22</xref>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
###xml 767 775 <span type="species:ncbi:9606">Children</span>
Saposin C deficient (C-/-) mice (23) were generated by introducing a Cys --> Pro substitution in the saposin C region of prosaposin. Substitution of this conserved cysteine (Cys) breaks one of the three disulfide bridges of saposin C and resulted in the specific deficiency of saposin C. This strategy has been used to produce several single and double saposin deficient mice (36,37). Saposin C-/- were cross-bred with point mutated GCase V394L homozygotes (4L/4L) (22) to generate C-/-;4L/wt and C+/-;4L/4L. 4L;C* mice (C-/-;4L/4L) were produced by intercrossing C-/-; 4L/wt and C+/-;4L/4L. The strain background of 4L;C* was C57BL/6J/129SvEV. The mice were maintained in microisolators in accordance with institutional guidelines under IACUC approval at Cincinnati Children's Hospital Research Foundation.
###end p 40
###begin title 41
Tissue collection and immunohistochemistry
###end title 41
###begin p 42
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C14">14</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C38">38</xref>
###xml 962 964 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C39">39</xref>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 478 483 <span type="species:ncbi:10090">mouse</span>
###xml 489 492 <span type="species:ncbi:9823">pig</span>
###xml 557 562 <span type="species:ncbi:10090">mouse</span>
###xml 619 622 <span type="species:ncbi:10116">rat</span>
###xml 628 633 <span type="species:ncbi:10090">mouse</span>
###xml 709 713 <span type="species:ncbi:9925">goat</span>
###xml 719 724 <span type="species:ncbi:10090">mouse</span>
###xml 789 793 <span type="species:ncbi:9925">goat</span>
###xml 799 802 <span type="species:ncbi:10116">rat</span>
###xml 857 862 <span type="species:ncbi:10090">mouse</span>
###xml 868 871 <span type="species:ncbi:9823">pig</span>
###xml 881 886 <span type="species:ncbi:10090">mouse</span>
###xml 944 949 <span type="species:ncbi:10090">mouse</span>
###xml 1071 1076 <span type="species:ncbi:10090">mouse</span>
###xml 1131 1135 <span type="species:ncbi:9925">goat</span>
###xml 1141 1146 <span type="species:ncbi:10090">mouse</span>
###xml 1198 1203 <span type="species:ncbi:10090">Mouse</span>
###xml 1253 1258 <span type="species:ncbi:10090">mouse</span>
###xml 1310 1313 <span type="species:ncbi:10116">rat</span>
###xml 1412 1415 <span type="species:ncbi:10116">Rat</span>
###xml 1455 1459 <span type="species:ncbi:9925">goat</span>
###xml 1465 1468 <span type="species:ncbi:10116">rat</span>
The 4L;C* and strain-matched WT mice were subjected to CO2 narcosis and then, perfused with saline followed by 4% paraformaldehyde before tissue dissection. The tissues were fixed in 10% formalin or 4% paraformaldehyde and processed for paraffin or frozen blocks, respectively. Paraffin sections of brain were stained with H&E. Karnovsky's fixative was used for ultrastructural studies. CD68 monoclonal antibody staining was as described (14). Frozen sections were stained with mouse anti-pig glial fibrillary acidic protein (GFAP) that detects astrocytes, mouse anti-recombinant p62 that is an autophagic receptor and rat anti-mouse Lamp2 that is a late endosome and lysosomal membrane protein. Biotinylated goat anti-mouse followed by streptavidin-conjugated fluorescent 488 (green) and goat anti-rat conjugated to FITC were applied to the sections. Both mouse anti-pig GFAP and mouse anti-recombinant p62 antibodies have reactivities in the mouse tissues (38,39). Colocalization of p62 in neuron, astrocyte or microglial cells was carried out on frozen sections using mouse anti-recombinant p62 (1:100) followed by biotinylated goat anti-mouse and streptavidin-conjugated fluorescent 610 (red). Mouse anti-NeuN conjugated to Alexa Fluor 488 (1:100), mouse anti-GFAP conjugated to Alexa Fluor 488 (1:100) or rat anti-CD68 (1:100) were applied as marker for neuron, astrocyte or microglial cells, respectively. Rat anti-CD68 was detected by biotinylated goat anti-rat and streptavidin-conjugated fluorescent 488 (green). DAPI (blue) in anti-fade were used for cell nuclei staining.
###end p 42
###begin title 43
Tissue GSL analyses
###end title 43
###begin p 44
###xml 990 991 990 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
GSLs in the tissues lysate (cortex, midbrain, liver and lung) were extracted and analyzed by LC/MS at the Lipidomic Core in Medical University of South Carolina. The GSL content was normalized to phosphate content in the same sample after lipid extraction. (GC and GalCer were not separated by LC/MS analysis.) Because 4L;C* mice had normal levels of saposin A and galactosylceramidase, 4L;C* and WT mice would have the same levels of GalCer. The alterations of GC and GalCer in the analysis will reflect the changes for GC. The data are presented as fold-change of GC in 4L;C* relative to WT after being normalized to phosphate content in the same sample. Hippocampal tissues were analyzed by a modified method in order to separate GC from GalCer at the Lipidomic Core in University of South Carolina. GC, GS and GalCer content in hippocampus were normalized to mg protein in the same samples. Three animals for each genotype were included in the analyses. Data were analyzed by Student's t-test.
###end p 44
###begin title 45
GCase activity and protein analyses
###end title 45
###begin p 46
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C40">40</xref>
###xml 362 364 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C14">14</xref>
###xml 525 526 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 294 299 <span type="species:ncbi:10090">Mouse</span>
Mouse tissues were homogenized and their GCase activities were determined fluorometrically with 4MU-Glc in 0.25% Na taurocholate and 0.25% Triton X-100 in the presence and absence of CBE (40). Assay mixtures were incubated for 60 min (37degreesC). WT control tissues were analyzed in parallel. Mouse liver GCase protein detection by immunoblot was as described (14). The amounts of GCase protein were quantitated by ImageQuant software relative to the amount of beta-actin in the same sample. Data were analyzed by Student's t-test.
###end p 46
###begin title 47
Electrophysiology
###end title 47
###begin p 48
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C41">41</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP580C39">39</xref>
###xml 860 861 836 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 867 868 843 844 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1764 1768 <span type="species:ncbi:10090">mice</span>
LTP was measured using the MED64 multielectrode array (Alpha Med Sciences, Kadoma, Japan) (41) as described previously (39). Animals were anesthetized using isofluorane and decapitated. Brains were removed and placed in an ice cold solution of aCSF. Parasagittal sections (350 microm) of the hippocampus were collected using a vibrotome and transferred to a warm (32degreesC), constantly oxygenated aCSF bath for a minimum of 1 h. Slices were transferred to the recording chamber, which consists of an 8 x 8 electrode array. Electrodes are 50 microm and are spaced 150 microm apart. Slices were placed so that the CA1 region of the hippocampus was placed across the grid, with recordings coming from the Schaffer collateral pathway. The section was constantly perfused with warmed (32degreesC) aCSF at a flow rate of 2 mL/min and supplied with humidified 95% O2/5% CO2. A stimulation and recording channel were selected out of the 64 possible electrodes. Single-pulse stimuli were delivered from the stimulation channel and the slope of the line from the resulting EPSPs was measured from the defined recording channel. Stimulus amplitude was selected by determining maximum response slope and then selecting a stimulus amplitude that produced a response that was approximately40% of the maximal response. Baseline recordings were collected for a minimum of 10 min. Following baseline, a theta burst stimulus (TBS; 5 Hz for 2 s) was applied to the slice from the stimulation channel. Single-pulse stimuli were again delivered and the resulting EPSPs were collected 1/min for 90 min following TBS. LTP was calculated by taking the percent increase in slope following TBS. Data were analyzed using Performer 2.0 software (Alpha Med Sciences). Six WT and eight 4L;C* mice were used in this study with two slices used per animal. The average of the two slices per animal was used in the subsequent analysis. Data were analyzed using a general linear model ANOVA with gene as a between subject factor and time as a repeated factor.
###end p 48
###begin title 49
FUNDING
###end title 49
###begin p 50
###xml 60 63 60 63 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NIH</funding-source>
###xml 63 67 63 67 <?release-delay 12|0?>
###xml 67 79 67 79 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C06 PR018823</award-id>
###xml 88 124 88 124 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Medical University of South Carolina</funding-source>
###xml 184 197 184 197 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R01 ES 015689</award-id>
###xml 244 267 244 267 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NS/DK 36681 and DK36729</award-id>
The authors thank the Lipidomics Core, supported in part by NIH12|0C06 PR018823, at the Medical University of South Carolina. Electrophysiology study was support by a grant to M.T.W. (R01 ES 015689). This work was supported by grants to G.A.G (NS/DK 36681 and DK36729).
###end p 50
###begin title 51
ACKNOWLEDGEMENTS
###end title 51
###begin p 52
The authors thank Venette Inskeep, Matt Zamzow, Brian Quinn and Juying Xu for their technical assistance, Lisa McMillin, Meredith Farmer, Sabina Sylvest, Georgianne Ciraolo and Chris Woods for skilled tissue preparation and photomicrographs, and Brandy Morris for her clerical expertise.
###end p 52
###begin p 53
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 53
###begin title 54
REFERENCES
###end title 54
###begin article-title 55
Gaucher disease: complexity in a 'simple' disorder
###end article-title 55
###begin article-title 56
###xml 54 57 <span type="species:ncbi:9606">GBA</span>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease
###end article-title 56
###begin article-title 57
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease
###end article-title 57
###begin article-title 58
Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies
###end article-title 58
###begin article-title 59
Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease
###end article-title 59
###begin article-title 60
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype
###end article-title 60
###begin article-title 61
Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease
###end article-title 61
###begin article-title 62
Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies
###end article-title 62
###begin article-title 63
Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell
###end article-title 63
###begin article-title 64
Proteolytic processing patterns of prosaposin in insect and mammalian cells
###end article-title 64
###begin article-title 65
Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation
###end article-title 65
###begin article-title 66
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Gaucher disease mouse models: point mutations at the acid {beta}-glucosidase locus combined with low-level prosaposin expression lead to disease variants
###end article-title 66
###begin article-title 67
Molecular imaging of membrane interfaces reveals mode of beta-glucosidase activation by saposin C
###end article-title 67
###begin article-title 68
Molecular and cell biology of acid beta-glucosidase and prosaposin
###end article-title 68
###begin article-title 69
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene
###end article-title 69
###begin article-title 70
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse
###end article-title 70
###begin article-title 71
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine models of acute neuronopathic Gaucher disease
###end article-title 71
###begin article-title 72
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels
###end article-title 72
###begin article-title 73
###xml 74 89 <span type="species:ncbi:10090">transgenic mice</span>
Prosaposin: threshold rescue and analysis of the 'neuritogenic' region in transgenic mice
###end article-title 73
###begin article-title 74
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease
###end article-title 74
###begin article-title 75
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Specific saposin C deficiency: CNS impairment and acid {beta}-glucosidase effects in the mouse
###end article-title 75
###begin article-title 76
Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy
###end article-title 76
###begin article-title 77
NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets
###end article-title 77
###begin article-title 78
Type 2 and type 3 Gaucher disease: a morphological and biochemical study
###end article-title 78
###begin article-title 79
Light microscopic and ultrastructural study on CNS lesions in infantile Gaucher's disease
###end article-title 79
###begin article-title 80
###xml 36 41 <span type="species:ncbi:9606">child</span>
Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings
###end article-title 80
###begin article-title 81
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation
###end article-title 81
###begin article-title 82
Neuropathology provides clues to the pathophysiology of Gaucher disease
###end article-title 82
###begin article-title 83
Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3
###end article-title 83
###begin article-title 84
Enhanced calcium release in the acute neuronopathic form of Gaucher disease
###end article-title 84
###begin article-title 85
Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms
###end article-title 85
###begin article-title 86
Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options
###end article-title 86
###begin article-title 87
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human glucosylsphingosine glucosyl hydrolase and comparison with glucosylceramidase
###end article-title 87
###begin article-title 88
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse
###end article-title 88
###begin article-title 89
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking
###end article-title 89
###begin article-title 90
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2
###end article-title 90
###begin article-title 91
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice
###end article-title 91
###begin article-title 92
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 106 112 <span type="species:ncbi:10090">murine</span>
###xml 117 122 <span type="species:ncbi:9606">human</span>
Turnover and distribution of intravenously administered mannose-terminated human acid beta-glucosidase in murine and human tissues
###end article-title 92
###begin article-title 93
Long-term recording of LTP in cultured hippocampal slices
###end article-title 93

